What specific medical conditions does apotex's ruxolitinib treat?

What ruxolitinib (Apotex) is used to treat

Apotex’s ruxolitinib is used for specific blood-related conditions, including:

- Myelofibrosis (including post–polycythemia vera myelofibrosis and post–essential thrombocythemia myelofibrosis) [1].
- Polycythemia vera (PV) in adults who are resistant to hydroxyurea or cannot tolerate hydroxyurea [1].
- Graft-versus-host disease (GVHD) that is steroid-refractory in adults and steroid-refractory acute GVHD in pediatric patients [1].

Which ruxolitinib indications are specifically for adults vs children?

• Adults: myelofibrosis and polycythemia vera, and GVHD indications in adults are included [1].
  
• Children: pediatric use is tied to steroid-refractory acute GVHD [1].
  
  

How should “treat” be understood for these conditions?

In these indications, ruxolitinib is prescribed to address the underlying disease process and/or its symptoms and complications as defined by the approved clinical indications (not as a cure) for the listed conditions [1].

Sources

[1] https://www.apotex.com/us-en/products/ruxolitinib